The effects of MYO- Inositol and metformin on oxidative stress and homocysteine levels in patients with polycystic ovary syndrome

Phase 2

• Conditions: Polycystic ovary syndrome.; Polycystic ovary syndrome; E28.2

• Registration Number: IRCT20190508043516N1
• Lead Sponsor: Dezfoul University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 October 2019

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 40

Inclusion Criteria

Polycystic ovary syndrome

Exclusion Criteria

Diabetes mellitus
Hyperprolactinemia
Congenital adrenal hyperplasia
Thyroid disorders
Cushing's syndrome
Liver and kidney disorders
Hypertension
Hemoglobinopathy

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Homocysteine. Timepoint: Beginning of study, three months after the intervention. Method of measurement: Elisa kit.;Oxidative stress factors. Timepoint: Beginning of study, three months after the intervention. Method of measurement: Elisa kit.